Conray 43 and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Conray 43 and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: iothalamate
Brand name: Conray, Conray 30, Conray 43, Cysto-Conray II
Synonyms: Iothalamate Meglumine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conray 43-Insulin degludec
- Conray 43-Insulin Degludec (U-100) Prefilled Pens
- Conray 43-Insulin Degludec (U-100) Vials
- Conray 43-Insulin Degludec (U-200) Prefilled Pens
- Conray 43-Insulin degludec and liraglutide
- Conray 43-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Consensi
- Insulin aspart, recombinant Subcutaneous-Constulose
- Insulin aspart, recombinant Subcutaneous-Contac 12-Hour
- Insulin aspart, recombinant Subcutaneous-Contac Cold
- Insulin aspart, recombinant Subcutaneous-Contac Cold+Flu Cooling Night
- Insulin aspart, recombinant Subcutaneous-Contac Cold+Flu Max Strength